| Page 6
850-474-8988

Archives

Author Archive for: ‘Endo-World’

  • New Clinical Guidelines Issued for Esophageal Cancer

    The Society of Thoracic Surgeons (STS) has released a set of clinical-practice guidelines to assist in the diagnosis and treatment of localized esophageal cancer. One of the key recommendations is that endoscopy with biopsy is the diagnostic test of choice for esophageal cancer. Another key …

    Read More
  • Picnic Pathogens: Treating Foodborne Illness

    An estimated 48 million cases of food poisoning occur annually in the United States that result in approximately 128,000 hospitalizations and 3,000 deaths.  Foodborne illness can be caused by bacteria and viruses, parasites, mold, toxins, and contaminants, as well as allergens.

    Read More
  • Optimum Performance: Eating too much red meat could put you in danger zone

    Red meat consumers take note: according to a recent study published in the Archive of Internal Medicine, “eating red meat is associated with a sharply increased risk of death from cancer and heart disease.”

    Read More
  • FDA Limits Duration, Usage of Tolvaptan Due to Possible Liver Injury

    An increased risk of liver injury was observed in recent large clinical trials evaluating tolvaptan for a new use in patients with autosomal dominant polycystic kidney disease (ADPKD)

    Read More
  • Prescribing Exercise Before and During Cancer Treatment May Lead to Better Outcomes

    Prescribing an exercise regimen for patients with cancer prior to and during treatment may lead to a better quality of life and less fatigue, according to researchers at Henry Ford Hospital in Detroit, MI.

    Read More
  • Amitiza Approved for Opioid-Induced Constipation

    Sucampo and Takeda announced that the FDA has approved the supplemental New Drug Application (sNDA) for Amitiza (lubiprostone) for the treatment of opioid-induced constipation in adult patients with chronic non-cancer pain.

    Read More
  • Bydureon Warning for MTC and Acute Pancreatitis

    The FDA has determined that a Risk Evaluation and Mitigation Strategy (REMS) is necessary to ensure that the benefits of Bydureon (exenatide extended-release for injectable suspension; Amylin) outweigh the potential risks including  medullary thyroid carcinoma (MTC) and acute pancreatitis.

    Read More
  • GLP-1 Therapies Linked to Increased Pancreatitis

    A recent study published in JAMA Internal Medicine concluded that treatment with the GLP-1 based therapies sitagliptin and exenatide in adults with type 2 diabetes mellitus was associated with increased odds of hospitalization for acute pancreatitis.

    Read More
  • Jp COLONOSCOPY 3 Popup

    Report Affirms Lifesaving Role of Colonoscopy

    In patients tracked for as long as 20 years, the death rate from colorectal cancer was cut by 53 percent in those who had the test and whose doctors removed precancerous growths, known as adenomatous polyps, researchers reported on Wednesday in The New England Journal …

    Read More
  • What to expect during your colonoscopy

    This new educational video for GI patients, produced by the ACG Institute for Clinical Research and Education, underscores the lifesaving importance of colorectal screening by colonoscopy. The video instills confidence in patients about the effectiveness, safety and importance of colonoscopy. Featuring the experience of a …

    Read More
Page 6 of 7« First...«34567»

© Copyright 2013-2020 Endoscopy Center. All Rights Reserved Privacy Policy | Site Map

Back to the Top